Clinical Trial – An Introduction to Essential Prerequisites

Authors

  • Bobby Paul
  • Indranil Saha
  • Sanjay Kumar
  • Gautam Ghose

DOI:

https://doi.org/10.53553/JCH.v02i01.008

Keywords:

.

Abstract

In today’s global scientific era, clinical trials are the mainstay for bringing newer and better drugs to market and it has become an indispensable part of the drug discovery process to ensure safety and efficacy of any new drug. According to the Associated Chambers of Commerce and Industry, India is set to grab clinical trials business valued at approximately US$ 1 billion by 2010, up from US$ 200 million last year, making the subcontinent one of the world’s preferred destinations for clinical trials. Drug companies are drawn to India for several reasons, including a techni¬cally competent workforce, patient availability, low costs and a friendly drug-control system which is good news for Indian economy. On the contrary, the booming clinical trial industry is raising concerns because of lack of regulations regarding trials by private drug companies, uneven application of protocol for informed consent and proper ethical review 1.This article tries to give a general overview regarding different steps and criteria of conduction of clinical trials.

Downloads

Published

2020-10-24

How to Cite

Paul, B. ., Saha, I. ., Kumar, S. ., & Ghose, G. . (2020). Clinical Trial – An Introduction to Essential Prerequisites. Journal of Comprehensive Health, 2(1), 57–64. https://doi.org/10.53553/JCH.v02i01.008

Issue

Section

Continued Medical Education

Most read articles by the same author(s)